The Maker of Ozempic Is Trying to Block Compounded Versions of Its Blockbuster Drug

Novo Nordisk has asked the FDA to block production of compounded copies of Ozempic, arguing that it’s too difficult to do safely. It’s the latest escalation in a brewing war between pharmaceutical companies and compounders.